Name of the Wave: Recent Advances in ATTR-CM Therapy
Date of the Wave: 26th of September 2024 (Next Thursday)
Time: 19:00 – 20:00 (GMT+4) UAE Time
Project Overview:
Recent Advances in ATTR-CM Therapy” hosted by the ECS Imaging Working Group provides a comprehensive update on the latest therapeutic developments in transthyretin amyloid cardiomyopathy (ATTR-CM). It highlights innovative imaging techniques used for diagnosis and monitoring, along with emerging treatment strategies that target both the disease mechanism and patient outcomes.
Webinar Moderators
Webinar Speakers
Agenda
Target Audience
Webinar Moderators
Firas Al Badarin (UAE)
Mazen Hanna (USA)
Webinar Speakers
Ahmed Masri (USA)
Mariana Fontana (UK)
Agenda
- 7:00-7:05
Introduction and welcome
Firas Al Badran
- 7:05-7:25
Role of TTR gene silencers in treating patients with ATTR-CM (HELIOS B Trial)
Mariana Fontana - 7:25-7:45
Novel ATTR stabilizers and their impact on prognosis of patients with ATTR-CM (ATTRIBUTE-CM Trial)
Ahmed Masri - 7:45-8:00
Q&A
Target Audience
- Cardiologists
- Radiologists
- Internal medicine specialists
- Healthcare professionals
- Medical researchers
- Imaging specialists
- Clinical practitioners